How often should AMD patients have their eyes monitored? 

Age related macular degeneration is a progressive condition that requires a carefully structured monitoring plan to ensure that any changes in vision are caught early. Because the condition can transition from a stable dry state to an active wet state within a very short timeframe, the frequency of check-ups is a critical component of eye care in the United Kingdom. These intervals are not the same for everyone but are instead tailored to the specific stage of the disease and the level of risk to the patient’s central vision. For some, monitoring might involve a simple annual visit to a high street optician, while for others, it may mean monthly visits to a specialist hospital eye clinic for detailed scans and treatment. 

What We’ll Discuss in This Article 

• Recommended monitoring intervals for early and intermediate stages of the condition. 

• The rigorous clinical schedule required for managing active wet AMD. 

• How the “Treat and Extend” pathway adjusts monitoring based on patient response. 

• The role of the patient in performing regular self-monitoring at home. 

• When to bypass the standard schedule for an urgent medical assessment. 

• The specific technologies used during monitoring to track macular stability. 

• How UK clinical guidelines determine the safest time between appointments. 

Monitoring intervals for early and intermediate AMD 

In the initial stages of age-related macular degeneration, the primary goal of monitoring is to track the progression of the disease and identify any signs that it may be transitioning into the more serious wet form. For patients diagnosed with early or intermediate dry AMD, clinical guidance in the UK usually recommends a routine eye examination every 12 to 24 months. These appointments are typically conducted by a high street optometrist who can use advanced imaging to monitor the size and number of drusen, the small waste deposits that accumulate under the retina. 

If the condition is classified as intermediate, meaning the drusen are larger or there are significant pigment changes, the optometrist may suggest more frequent visits, such as every 6 to 12 months. This allows for a more detailed comparison of retinal photographs and scans over time. During these visits, the specialist will also check for “geographic atrophy,” which is the gradual thinning of the macular tissue. Because this form of the disease progresses slowly, these longer intervals are generally considered safe as long as the patient remains vigilant between appointments. Detailed information on monitoring early AMD can be found on the NHS website. 

The urgent schedule for active wet AMD 

When the condition transitions into the “wet” form, the monitoring schedule becomes significantly more intensive. Wet AMD involves the growth of abnormal blood vessels that leak fluid or blood, which can cause rapid and irreversible vision loss. In the UK, the standard of care for a new diagnosis of wet AMD begins with a “loading phase,” which typically involves three or four anti VEGF injections administered approximately four weeks apart. During this initial phase, the patient is monitored very closely, often at every injection appointment, to see how the macula is responding to the medication. 

Once the loading phase is complete and the macula has ideally become “dry” (free of leakage), the monitoring frequency is gradually adjusted. If the condition remains active or if the fluid returns quickly, the patient may continue to be seen every four to six weeks for a long period. This high frequency is necessary because the window for treating a flare up is very narrow. In many NHS hospitals, these appointments involve a visual acuity test and an OCT (Optical Coherence Tomography) scan to provide a detailed cross section of the macula, ensuring that no new leakage is missed. 

Understanding the “Treat and Extend” pathway 

The most common long term monitoring strategy used in the United Kingdom for wet AMD is known as the “Treat and Extend” pathway. This approach is designed to provide a personalised schedule that maintains the health of the macula while reducing the burden of frequent hospital visits on the patient. Under this regimen, a patient receives an injection at every visit, but the time between those visits is gradually increased if the eye remains stable and dry. 

For example, if the macula is stable at a four-week interval, the specialist may extend the next appointment to six weeks. If it remains stable again, the interval might be extended to eight, ten, or even twelve weeks. The maximum interval allowed under most UK protocols is 16 weeks. If at any point the OCT scan shows that fluid has returned or that the vision has declined, the interval is immediately reduced to ensure the condition is brought back under control. This proactive method is supported by NICE guidance on AMD management, as it aims to prevent flare ups rather than just treating them after they occur. 

The role of self-monitoring at home 

Beyond formal clinical appointments, patients in the UK are encouraged to play an active role in monitoring their own vision through regular home checks. This is particularly important for those with dry AMD or those whose wet AMD is currently stable, as it helps identify a sudden change between scheduled visits. The most common tool for this is the Amsler grid, a square of straight lines with a dot in the centre. 

Patients are typically advised to check each eye individually using the grid at least once a week. By covering one eye and focusing on the centre dot, they can look for any lines that appear wavy, distorted, or missing. If any such changes are noticed, it is an indication that the condition may have become “active” and requires an assessment sooner than the next planned appointment. This self-monitoring does not replace the need for professional check-ups but serves as an essential safety net for detecting the rapid onset of wet AMD. 

When to deviate from the routine schedule 

While a monitoring schedule provides a helpful structure, it is not a rigid rule. There are several situations where a patient should seek an urgent assessment even if their next appointment is many weeks away. In the UK healthcare system, sudden changes in central vision are treated as a medical priority. If a patient notices a new dark “smudge” in their central vision, a sudden drop in the clarity of print, or a new distortion where straight lines (like door frames) look bent, they should contact their eye clinic or an optometrist immediately. 

Most NHS hospital eye departments provide a “fast track” or “emergency macula” service for their existing patients. If a patient is worried about a sudden change, they are often advised to call the AMD coordinator or the eye clinic triage line rather than waiting for a GP referral. This ensures that any new leakage can be addressed within the 14-day target set by national guidelines, which is the most effective way to prevent permanent scarring of the macula. 

Monitoring for geographic atrophy (advanced dry AMD) 

For patients with geographic atrophy, the advanced form of dry AMD, the monitoring frequency is often different because there is currently no standard injection treatment to “stop” the thinning of the tissue. Monitoring in these cases is primarily focused on assessing the functional impact on the patient’s life and ensuring they have access to low vision services. Appointments are usually scheduled every 6 to 12 months. 

During these visits, the ophthalmologist or optometrist will use specialized scans, such as Fundus Autofluorescence (FAF), to measure the size of the atrophic patches. This information helps the specialist provide a more accurate prognosis for the patient’s future vision and helps determine when they might be eligible for certification of sight impairment. It is also a time to check if any areas of the dry AMD are transitioning into wet AMD, as this can still happen even in the advanced stages of the dry form. 

Monitoring Frequency Summary Table 

Stage of AMD	Typical Monitoring Interval	Primary Care Setting
Early Dry AMD	Every 12 to 24 months	High street optician
Intermediate Dry AMD	Every 6 to 12 months	High street optician
Active Wet AMD (Loading)	Every 4 weeks	Hospital eye clinic
Stable Wet AMD (Extension)	Every 8 to 16 weeks	Hospital eye clinic
Geographic Atrophy	Every 6 to 12 months	Optician or Hospital
High Risk Second Eye	Every 6 to 12 months	Optician or Hospital

Conclusion 

The monitoring frequency for age related macular degeneration is tailored to the severity of the disease and the risk of rapid vision loss. While those with early dry AMD may only need biennial check-ups, those with active wet AMD require intensive monitoring that can occur as often as every four weeks. Through the “Treat and Extend” pathway and regular self-monitoring at home, the UK healthcare system aims to provide a proactive and personalised approach to saving sight. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot 

This article provides a medically grounded overview of the monitoring schedules used for macular degeneration in the United Kingdom. The content was prepared by the Medical Content Team and reviewed by Dr. Rebecca Fernandez, a UK trained physician with experience across internal medicine and acute care. All information presented is strictly aligned with the clinical pathways and “Treat and Extend” protocols established by the NHS and the National Institute for Health and Care Excellence (NICE) to ensure patient safety and accurate information.